Vicore Pharma Holding AB (publ) (VICO.ST)
SEK 7.77
(1.17%)
SEK 7.77
(1.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 508 Thousand |
| Cost of Revenue | 3.42 Million | 3.61 Million | 3.59 Million | 3.53 Million | 1.33 Million | 21.75 Million |
| Gross Profit | -3.42 Million | -3.61 Million | -3.59 Million | -3.53 Million | -1.33 Million | -21.24 Million |
| Operating Expenses | 321.5 Million | 287.49 Million | 293.42 Million | 149.47 Million | 94.01 Million | 42.09 Million |
| Selling, General and Administrative Expenses | 44.59 Million | 37.52 Million | 21.6 Million | 24.98 Million | 26.87 Million | 8.62 Million |
| Research and Development Expenses | 272.87 Million | 249.96 Million | 271.81 Million | 142.02 Million | 67.04 Million | 20.46 Million |
| Other Expenses | 617 Thousand | - | - | -17.53 Million | 91 Thousand | 13 Million |
| Cost and Expenses | 321.5 Million | 287.49 Million | 293.42 Million | 149.47 Million | 94.01 Million | 42.09 Million |
| Operating Income | -321.5 Million | -290.72 Million | -294.81 Million | -149.53 Million | -94.01 Million | -44.28 Million |
| Interest Expense | 358 Thousand | 8000.00 | 11 Thousand | 6000.00 | 27 Thousand | 352 Thousand |
| Income Tax Expense | -384 Thousand | -384 Thousand | -254 Thousand | -453 Thousand | -245 Thousand | 20.25 Million |
| Earnings before Tax | -311.32 Million | -288.8 Million | -296.73 Million | -147.31 Million | -93.32 Million | -21.68 Million |
| Net Income | -310.94 Million | -288.42 Million | -296.48 Million | -146.86 Million | -93.08 Million | -21.68 Million |
| Earnings Per Share Basic | -3.22 | -3.99 | -4.25 | -2.71 | -2.16 | -0.95 |
| Earnings Per Share Diluted | -3.22 | -3.99 | -4.25 | -2.71 | -2.16 | -0.95 |
| Weighted Average Shares Outstanding | 96.55 Million | 72.21 Million | 69.67 Million | 54.24 Million | 43.04 Million | 22.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 96.55 Million | 72.21 Million | 69.67 Million | 54.24 Million | 43.04 Million | 22.88 Million |
| Gross Margin | - | - | - | - | - | -41.83 |
| EBIT Margin | - | - | - | - | - | -49.22 |
| Profit Margin | - | - | - | - | - | -42.68 |
| EBITDA | -317.46 Million | -286.2 Million | -293.12 Million | -143.77 Million | -92.51 Million | -38.24 Million |
| Earnings Before Tax Margin | - | - | - | - | - | -87.17 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 104.24 Million | - | - | - | - |
| Cost of Revenue | 839 Thousand | - | 3.42 Million | 51.39 Million | 840 Thousand | 839 Thousand |
| Gross Profit | -839 Thousand | 104.24 Million | -3.42 Million | -51.39 Million | -840 Thousand | -839 Thousand |
| Operating Expenses | 61.89 Million | 77.22 Million | 317.46 Million | 69.42 Million | 65.05 Million | 69.79 Million |
| Selling, General and Administrative Expenses | 12.71 Million | 9.88 Million | - | 16.57 Million | 10.36 Million | 8.81 Million |
| Research and Development Expenses | 49.18 Million | 67.34 Million | - | 52.84 Million | 55.06 Million | 60.33 Million |
| Other Expenses | 404 Thousand | - | - | - | - | - |
| Cost and Expenses | 62.73 Million | 78.06 Million | 320.88 Million | 120.81 Million | 65.05 Million | 69.79 Million |
| Operating Income | -62.73 Million | 26.17 Million | -320.88 Million | -120.81 Million | -65.05 Million | -69.79 Million |
| Interest Expense | 5000.00 | - | 358 Thousand | -356 Thousand | - | 2000.00 |
| Income Tax Expense | -96 Thousand | -96 Thousand | -384 Thousand | -96 Thousand | -96 Thousand | -96 Thousand |
| Earnings before Tax | -56.42 Million | 31.61 Million | -311.32 Million | -111.98 Million | -63.65 Million | -69.29 Million |
| Net Income | -56.32 Million | 31.71 Million | -310.94 Million | -111.89 Million | -63.56 Million | -69.2 Million |
| Earnings Per Share Basic | -0.50 | 0.28 | - | -1.00 | -0.58 | -0.85 |
| Earnings Per Share Diluted | -0.50 | 0.28 | - | -1.00 | -0.58 | -0.85 |
| Weighted Average Shares Outstanding | 111.72 Million | 111.72 Million | 96.55 Million | 111.72 Million | 108.76 Million | 81.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 111.72 Million | 111.72 Million | 96.55 Million | 111.72 Million | 108.76 Million | 81.84 Million |
| Gross Margin | - | 1.00 | - | - | - | - |
| EBIT Margin | - | 0.26 | - | - | - | - |
| Profit Margin | - | 0.30 | - | - | - | - |
| EBITDA | -61.89 Million | 27.01 Million | - | -69.42 Million | -63.65 Million | -69.29 Million |
| Earnings Before Tax Margin | - | 0.25 | - | - | - | - |
002004
MAGE
FMNL
MEI
SHAH
QCKSF